Elevated anticardiolipin antibodies have a low prevalence in unselected stroke patients, suggesting that screening should be reserved for patients under 50 years of age or those with suspected antiphospholipid syndrome.
No takes yet. Share an insight, caveat, or question.
Cautions against routine ACA screening in unselected stroke/TIA patients; leaves open value of targeted testing in those under 50.
Dahle et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: